Which of the following is not a difference between Biopharmaceutical and Pharmaceutical
Which of the following is not a difference between Biopharmaceutical and Pharmaceutical
The correct option is C Biopharmaceuticals are safer as they do not cause side-effects.
A biopharmaceutical, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from chemically synthesized pharmaceuticals, they include vaccines, blood, or blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. An inactivated vaccine (or killed vaccine) consists of virus particles which are grown in culture and then killed using a method such as heat or formaldehyde. Biopharmaceutical drugs are important therapeutic options as they provide an alternative to small molecule drugs for novel treatments of previously untreatable diseases. These drugs provide affordable options for addressing the healthcare needs of humankind. Through Biotechnology Industry Research Assistance Council (BIRAC) a Public Sector of DBT a number of Start-ups, SMEs and Biotech companies are developing such new drugs
Biopharmaceuticals are safer as they do not cause side-effects.
A biopharmaceutical, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from chemically synthesized pharmaceuticals, they include vaccines, blood, or blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. An inactivated vaccine (or killed vaccine) consists of virus particles which are grown in culture and then killed using a method such as heat or formaldehyde. Biopharmaceutical drugs are important therapeutic options as they provide an alternative to small molecule drugs for novel treatments of previously untreatable diseases. These drugs provide affordable options for addressing the healthcare needs of humankind. Through Biotechnology Industry Research Assistance Council (BIRAC) a Public Sector of DBT a number of Start-ups, SMEs and Biotech companies are developing such new drugs
